Published in J Urol on April 17, 2011
The 532-nm 180-W (GreenLight®) laser vaporization of the prostate for the treatment of lower urinary tract symptoms: how durable is the new side-fire fiber with integrated cooling system? Lasers Med Sci (2013) 0.78
Ablative efficiency of 532-nm laser vaporization compared to transurethral resection of the prostate: results from a prospective three-dimensional ultrasound volumetry study. World J Urol (2013) 0.77
Transurethral 160-W straight beam green laser vaporesection of the prostate: initial experience after 180 procedures. Springerplus (2016) 0.75
Photoselective Vaporesection of the Prostate with an End-firing Lithium Triborate Crystal Laser. Chin Med J (Engl) (2017) 0.75
Investigation on safety aspects of forward light propagation during laser surgery. Lasers Med Sci (2012) 0.75
Prostate volume reduction following pure transurethral bipolar plasma vaporization and conventional transurethral resection of the prostate: a prospective investigation using transrectal 3D ultrasound volumetry. World J Urol (2016) 0.75
Optical feedback-induced light modulation for fiber-based laser ablation. Lasers Med Sci (2014) 0.75
ARB: a software environment for sequence data. Nucleic Acids Res (2004) 58.27
Intensive Supportive Care plus Immunosuppression in IgA Nephropathy. N Engl J Med (2015) 4.78
Downsides of robot-assisted laparoscopic radical prostatectomy: limitations and complications. Eur Urol (2009) 2.76
Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases. Eur Urol (2008) 2.42
Tumour class prediction and discovery by microarray-based DNA methylation analysis. Nucleic Acids Res (2002) 2.34
X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study. J Am Soc Nephrol (2003) 2.12
Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol (2005) 2.03
Percutaneous nephrolithotomy with ultrasonography-guided renal access: experience from over 300 cases. BJU Int (2005) 1.91
Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations. Kidney Int (2012) 1.87
Is there a role for tamsulosin in the treatment of distal ureteral stones of 7 mm or less? Results of a randomised, double-blind, placebo-controlled trial. Eur Urol (2009) 1.87
Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. J Am Coll Cardiol (2008) 1.86
Bivariate phase-rectified signal averaging for assessment of spontaneous baroreflex sensitivity: pilot study of the technology. J Electrocardiol (2010) 1.70
Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature. Eur Urol (2013) 1.69
Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy. Eur Urol (2011) 1.62
Laser fibre deterioration and loss of power output during photo-selective 80-w potassium-titanyl-phosphate laser vaporisation of the prostate. Eur Urol (2008) 1.62
Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. Eur Urol (2008) 1.60
Life-threatening complication after right renal extracorporeal shock wave lithotripsy: large hepatic haematoma requiring embolisation of the right hepatic artery. Eur Urol (2007) 1.57
In vivo identification of uric acid stones with dual-energy CT: diagnostic performance evaluation in patients. Abdom Imaging (2009) 1.56
Intermediate-term results of retroperitoneoscopy-assisted cryotherapy for small renal tumours using multiple ultrathin cryoprobes. Eur Urol (2006) 1.53
Sexual function after transurethral resection of the prostate (TURP): results of an independent prospective multicentre assessment of outcome. Eur Urol (2007) 1.52
Urological surgery and antiplatelet drugs after cardiac and cerebrovascular accidents. J Urol (2010) 1.52
Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol (2013) 1.52
High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol (2005) 1.51
Laparoscopy in German urology: changing acceptance among urologists. Eur Urol (2008) 1.51
Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol (2006) 1.50
The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis. Eur Urol (2013) 1.47
Dual-energy computed tomography for the differentiation of uric acid stones: ex vivo performance evaluation. Urol Res (2008) 1.45
Lateral temperature spread of monopolar, bipolar and ultrasonic instruments for robot-assisted laparoscopic surgery. BJU Int (2014) 1.44
Retroperitoneoscopic living donor nephrectomy: a retrospective comparison to the open approach. Transplantation (2004) 1.39
KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clin Cancer Res (2011) 1.38
Is kidney surgery going to be minimally invasive in all cases? Eur Urol (2007) 1.38
MR imaging relaxometry allows noninvasive characterization of in vivo differentiation of muscle precursor cells. Radiology (2014) 1.38
Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). Eur Heart J (2008) 1.37
Long-term experience with surgical and conservative treatment of penile fracture. J Urol (2004) 1.37
Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma. Genes Chromosomes Cancer (2002) 1.28
Loss of PBRM1 expression is associated with renal cell carcinoma progression. Int J Cancer (2012) 1.27
Activities of MAP-kinase pathways in normal uroepithelial cells and urothelial carcinoma cell lines. Exp Cell Res (2003) 1.21
Periostin is up-regulated in high grade and high stage prostate cancer. BMC Cancer (2010) 1.21
FOXA1 promotes tumor progression in prostate cancer and represents a novel hallmark of castration-resistant prostate cancer. Am J Pathol (2011) 1.20
Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease. J Am Soc Nephrol (2005) 1.19
How to strengthen or weaken the HRV dependence on heart rate--description of the method and its perspectives. Int J Cardiol (2013) 1.18
Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol (2004) 1.18
Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative. Pediatr Nephrol (2012) 1.17
Oxygen producing biomaterials for tissue regeneration. Biomaterials (2007) 1.16
Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer. Int J Cancer (2006) 1.15
The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate. J Sex Med (2008) 1.15
Low-power holmium:YAG laser urethrotomy for treatment of urethral strictures: functional outcome and quality of life. J Endourol (2006) 1.15
Alport syndrome--insights from basic and clinical research. Nat Rev Nephrol (2012) 1.14
Laparoscopic radical prostatectomy--the experience of the German Laparoscopic Working Group. Eur Urol (2005) 1.14
Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol (2005) 1.12
The influence of extracellular matrix derived from skeletal muscle tissue on the proliferation and differentiation of myogenic progenitor cells ex vivo. Biomaterials (2009) 1.11
Engineering functional bladder tissues. J Tissue Eng Regen Med (2012) 1.10
Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma. Int J Cancer (2003) 1.10
Donor-site morbidity in buccal mucosa urethroplasty: lower lip or inner cheek? BJU Int (2005) 1.08
Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. Eur Urol (2009) 1.07
Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer. Clin Cancer Res (2009) 1.06
VHL gene mutations and their effects on hypoxia inducible factor HIFα: identification of potential driver and passenger mutations. Cancer Res (2011) 1.05
Thulium:yttrium-aluminium-garnet laser prostatectomy in men with refractory urinary retention. BJU Int (2009) 1.03
Profiling gastrin-releasing peptide receptor in prostate tissues: clinical implications and molecular correlates. Prostate (2011) 1.03
The mitochondrial electron transport chain is dispensable for proliferation and differentiation of epidermal progenitor cells. Stem Cells (2011) 1.03
Chyloretroperitoneum with secondary chylothorax after retroperitoneoscopic donor nephrectomy. Urology (2005) 1.01
An analysis of sexual health information on radical prostatectomy websites. BJU Int (2009) 1.01
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy. Int J Cancer (2009) 1.00
Reduction of PTEN and p27kip1 expression correlates with tumor grade in prostate cancer. Analysis in radical prostatectomy specimens and needle biopsies. Virchows Arch (2004) 1.00
Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy. Ann Surg Oncol (2011) 1.00
Self-inducible Bacillus subtilis expression system for reliable and inexpensive protein production by high-cell-density fermentation. Appl Environ Microbiol (2011) 0.99
Multiple mechanisms downregulate CDKN1C in human bladder cancer. Int J Cancer (2005) 0.98
MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer. PLoS One (2011) 0.97
Integrin α2-deficient mice provide insights into specific functions of collagen receptors in the kidney. Fibrogenesis Tissue Repair (2010) 0.96
Paracrine effects of mesenchymal stem cells enhance vascular regeneration in ischemic murine skin. Microvasc Res (2012) 0.96
Computed tomography perfusion imaging of renal cell carcinoma: systematic comparison with histopathological angiogenic and prognostic markers. Invest Radiol (2013) 0.96
Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. J Urol (2004) 0.95
Plasma leakage through glomerular basement membrane ruptures triggers the proliferation of parietal epithelial cells and crescent formation in non-inflammatory glomerular injury. J Pathol (2012) 0.95
Expression and activity of matrix metalloproteinases-2 and -9 in serum, core needle biopsies and tissue specimens of prostate cancer patients. Virchows Arch (2004) 0.95
Drug-induced granulomatous interstitial nephritis in a patient with ankylosing spondylitis during therapy with adalimumab. Am J Kidney Dis (2010) 0.95
Inner ear defects and hearing loss in mice lacking the collagen receptor DDR1. Lab Invest (2007) 0.94
Bacterial CpG-DNA accelerates Alport glomerulosclerosis by inducing an M1 macrophage phenotype and tumor necrosis factor-α-mediated podocyte loss. Kidney Int (2010) 0.94
Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. Hum Mutat (2005) 0.94
Reflex and tonic autonomic markers for risk stratification in patients with type 2 diabetes surviving acute myocardial infarction. Diabetes Care (2011) 0.94
Human Adipose-Derived Mesenchymal Stromal Cells May Promote Breast Cancer Progression and Metastatic Spread. Plast Reconstr Surg (2015) 0.93
Delayed infection of a pelvic lymphocele following robotic radical prostatectomy and pelvic lymphadenectomy: two cases. Urol Int (2009) 0.93
Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome. Nephrol Dial Transplant (2007) 0.93
Tin doping speeds up hole transfer during light-driven water oxidation at hematite photoanodes. Phys Chem Chem Phys (2014) 0.93
Intra-abdominal fire due to insufflating oxygen instead of carbon dioxide during robot-assisted radical prostatectomy: case report and literature review. Eur Urol (2010) 0.92
Spontaneous baroreflex sensitivity: prospective validation trial of a novel technique in survivors of acute myocardial infarction. Heart Rhythm (2012) 0.92
Prospective evaluation of irrigation fluid absorption during pure transurethral bipolar plasma vaporisation of the prostate using expired-breath ethanol measurements. BJU Int (2013) 0.92